Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Virios Therapeutics (VIRI US)
Watchlist
2
Analysis
Health Care
•
United States
Virios Therapeutics, Inc. operates as a biotechnology company. The Company develops novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. Virios Therapeutics serves patients in the United States.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Virios Therapeutics
•
14 Aug 2024 00:00
•
Issuer-paid
VIRI: Enrollment Complete in Phase 2a Long COVID Trial Results Expected in October 2024
On August 8, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the second quarter of 2024 and provided a business update. The...
Zacks Small Cap Research
Follow
146 Views
Share
bullish
•
Virios Therapeutics
•
14 May 2024 00:00
•
Issuer-paid
VIRI: Results for Phase 2 Long COVID Trial Expected in 2H24
On May 10, 2024, Virios Therapeutics, Inc. (VIRI) announced financial results for the first quarter of 2024 and provided a business update. The...
Zacks Small Cap Research
Follow
198 Views
Share
1
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x